Relationship between pharmaceutical company user fees and drug approvals in canada and Australia : A hypothesis-generating studyLEXCHIN, Joel.The Annals of pharmacotherapy. 2006, Vol 40, Num 12, pp 2216-2222, issn 1060-0280, 7 p.Article

Implications of pharmaceutical industry funding on clinical researchLEXCHIN, Joel R.The Annals of pharmacotherapy. 2005, Vol 39, Num 1, pp 194-197, issn 1060-0280, 4 p.Article

Foreign free riders and the high price of US medicinesLIGHT, Donald W; LEXCHIN, Joel.BMJ. British medical journal (International ed.). 2005, Vol 331, Num 7522, pp 958-960, issn 0959-8146, 3 p.Article

PHARMACEUTICAL R&D What do we get for all that money?LIGHT, Donald; LEXCHIN, Joel.BMJ (Overseas and retired doctors ed.). 2012, Vol 345, Num 7869, pp 22-25, issn 1759-2151, 4 p.Article

Prohibiting or 'managing' conflict of interest? A review of policies and procedures in three European drug regulation agenciesLEXCHIN, Joel; O'DONOVAN, Orla.Social science & medicine (1982). 2010, Vol 70, Num 5, pp 643-647, issn 0277-9536, 5 p.Article

The pharmaceutical industry as a medicines providerHENRY, David; LEXCHIN, Joel.Lancet (British edition). 2002, Vol 360, Num 9345, pp 1590-1595, issn 0140-6736, 6 p.Article

Pharmacovigilance in Europe and North America: Divergent approachesWIKTOROWICZ, Mary; LEXCHIN, Joel; MOSCOU, Kathy et al.Social science & medicine (1982). 2012, Vol 75, Num 1, pp 165-170, issn 0277-9536, 6 p.Article

Pharmaceutical industry sponsorship and research outcome and quality: systematic reviewLEXCHIN, Joel; BERO, Lisa A; DJULBEGOVIC, Benjamin et al.BMJ. British medical journal (International ed.). 2003, Vol 326, Num 7400, pp 1167-1170, issn 0959-8146, 4 p.Article

Adverse drug events in general practice patients in AustraliaROUGHEAD, Elizabeth E; LEXCHIN, Joel; MILLER, Graeme C et al.Medical journal of Australia. 2006, Vol 184, Num 7, issn 0025-729X, 315-316,321-324 [6 p.]Article

Assessing the quality of drug detailingMOLLNY, William; STRANG, David; GUYATT, Gordon et al.Journal of clinical epidemiology. 2002, Vol 55, Num 8, pp 825-832, issn 0895-4356Article

National Evaluation of Policies on Individual Financial Conflicts of Interest in Canadian Academic Health Science CentersLEXCHIN, Joel; SEKERES, Melanie; TABACK, Nathan et al.Journal of general internal medicine. 2008, Vol 23, Num 11, pp 1896-1903, issn 0884-8734, 8 p.Article

Everyday experiences of implicit rationing : comparing the voices of nurses in California and British ColumbiaBOURGEAULT, Ivy Lynn; ARMSTRONG, Pat; ARMSTRONG, Hugh et al.Sociology of health & illness (Print). 2001, Vol 23, Num 5, pp 633-653, issn 0141-9889Article

What do Canadians think about physician―pharmaceutical industry interactions?HOLBROOK, Anne; LEXCHIN, Joel; PULLENAYEGUM, Eleanor et al.Health policy (Amsterdam. Print). 2013, Vol 112, Num 3, pp 255-263, issn 0168-8510, 9 p.Article

Pharmaceutical Sales Representatives and Patient Safety: A Comparative Prospective Study of Information Quality in Canada, France and the United StatesMINTZES, Barbara; LEXCHIN, Joel; SUTHERLAND, Jason M et al.Journal of general internal medicine. 2013, Vol 28, Num 10, pp 1368-1375, issn 0884-8734, 8 p.Article

Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional surveyMINTZES, Barbara; BARER, Morris L; KRAVITZ, Richard L et al.BMJ. British medical journal (International ed.). 2002, Vol 324, Num 7332, pp 278-279, issn 0959-8146Article

Reporting of Conflicts of Interest in Meta-analyses of Trials of Pharmacological TreatmentsROSEMAN, Michelle; MILETTE, Katherine; BERO, Lisa A et al.JAMA, the journal of the American Medical Association. 2011, Vol 305, Num 10, pp 1008-1017, issn 0098-7484, 10 p.Article

Qualitative research and the politics of knowledge in an age of evidence : Developing a research-based practice of immanent critiqueMYKHALOVSKIY, Eric; ARMSTRONG, Pat; ARMSTRONG, Hugh et al.Social science & medicine (1982). 2008, Vol 67, Num 1, pp 195-203, issn 0277-9536, 9 p.Article